TrialThe Pediatric infectious disease journal2018

Safety, Tolerability and Pharmacokinetics of MEDI8897, an Extended Half-life Single-dose Respiratory Syncytial Virus Prefusion F-targeting Monoclonal Antibody Administered as a Single Dose to Healthy Preterm Infants.

Joseph B Domachowske et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.